Publications by authors named "Phantica Yambo"
Article Synopsis
- The study aimed to assess the effectiveness of presumptive antimalarial treatment postpartum in reducing malaria incidence among mothers in Papua New Guinea.
- Participants were randomly assigned to receive either no treatment or artemisinin combination therapy (ACT), with no significant difference between the two types of ACT used.
- Results showed that those who received ACT had a significantly lower risk of developing malaria compared to the untreated group, indicating that administering ACT at delivery can effectively halve the risk of postpartum malaria.
Objectives: We aimed to assess safety, tolerability, and Plasmodium vivax relapse rates of ultra-short course (3.5 days) high-dose (1 mg/kg twice daily) primaquine (PQ) for uncomplicated malaria because of any Plasmodium species in children randomized to early- or delayed treatment.
Methods: Children aged 0.
Background: Passively acquired respiratory syncytial virus (RSV) neutralizing antibody protects against RSV-associated lower respiratory infections, but placental malaria (PM) and maternal hypergammaglobulinemia might interfere with transplacental immunoglobulin transport.
Methods: We measured RSV plaque-reduction neutralization (PRN) antibody in 300 full-term maternal/cord serum pairs in 2 cohorts in malaria-endemic Papua New Guinea: Alexishafen (2005-2008) and the Fetal Immunity Study (FIS) (2011-2013). We defined impaired transport as a cord-to-maternal titer ratio <1.